Skip to content
← Full study record

NCT01772719 · MORE INFO

Limitations, agreements, and source contact

Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid · Source last updated 2019-11-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
ctobcc@louisville.edu
organization
University of Louisville, James Graham Brown Cancer Center
phone
502-562-3429
title
James Graham Brown Cancer Center, Clinical Trials
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
ctobcc@louisville.edu
organization
University of Louisville, James Graham Brown Cancer Center
phone
502-562-3429
title
James Graham Brown Cancer Center, Clinical Trials

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice